Cargando…

Prognostic Assessment and Management of Liver Cirrhosis

Detalles Bibliográficos
Autores principales:	Qi, Xingshun, Arora, Ankur, Tang, Shanhong, Mancuso, Andrea, Romeiro, Fernando Gomes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5556990/ https://www.ncbi.nlm.nih.gov/pubmed/28835894 http://dx.doi.org/10.1155/2017/5326898

Ejemplares similares

Portal Hypertension
por: Sun, Mingyu, et al.
Publicado: (2018)

Correlation of Serum Cardiac Markers with Acute Decompensating Events in Liver Cirrhosis
por: Li, Miaomiao, et al.
Publicado: (2020)

Controversies in the Management of Portal Vein Thrombosis in Liver Cirrhosis
por: Mancuso, Andrea
Publicado: (2020)

Evolution of Nonmalignant Portal Vein Thrombosis in Liver Cirrhosis: A Pictorial Review
por: Xu, Shixue, et al.
Publicado: (2021)

U‐shaped relationship between subcutaneous adipose tissue index and mortality in liver cirrhosis
por: Zhu, Menghua, et al.
Publicado: (2022)

Transient portal vein thrombosis in liver cirrhosis
por: Qi, Xingshun, et al.
Publicado: (2018)

No Association between Ischemic Stroke and Portal Vein Thrombosis in Liver Cirrhosis
por: Zheng, Kexin, et al.
Publicado: (2020)

Diagnosis and Management of Cirrhosis-Related Osteoporosis
por: Santos, Lívia Alves Amaral, et al.
Publicado: (2016)

Computed Tomography Images of Spontaneous Portosystemic Shunt in Liver Cirrhosis
por: Yi, Fangfang, et al.
Publicado: (2022)

Human albumin infusion strategy in liver cirrhosis: liberal or restrictive?
por: Bai, Zhaohui, et al.
Publicado: (2021)

Xuebijing Injection Combined with Antibiotics for the Treatment of Spontaneous Bacterial Peritonitis in Liver Cirrhosis: A Meta-Analysis
por: Han, Dan, et al.
Publicado: (2018)

Safety and efficacy of risedronate for patients with esophageal varices and liver cirrhosis: a non-randomized clinical trial
por: Lima, Talles Bazeia, et al.
Publicado: (2019)

No Benefit of Hemostatic Drugs on Acute Upper Gastrointestinal Bleeding in Cirrhosis
por: An, Yang, et al.
Publicado: (2020)

Effect of Body Mass Index on the Prognosis of Liver Cirrhosis
por: Yin, Yue, et al.
Publicado: (2021)

Diagnostic and Prognostic Markers in Liver Cirrhosis
por: Augustin, Salvador, et al.
Publicado: (2011)

Adherence to Non-Selective Beta Blockers for Prevention of Variceal Bleeding in Cirrhotic Patients
por: An, Yang, et al.
Publicado: (2021)

Sarcopenia as a prognostic indicator of liver cirrhosis
por: Kim, Sung‐Eun, et al.
Publicado: (2021)

Spontaneous Resolution of Portal Vein Thrombosis in Cirrhosis: Where do we Stand, and Where will we Go?
por: Qi, Xingshun, et al.
Publicado: (2014)

Prognostic implications of trunk muscle mass in liver cirrhosis
por: Han, Jimin, et al.
Publicado: (2018)

The Impact of Sarcopenia and Its Rate of Change on Prognostic Value of Liver Cirrhosis
por: Kang, Seong Hee, et al.
Publicado: (2018)

Child–Pugh Versus MELD Score for the Assessment of Prognosis in Liver Cirrhosis: A Systematic Review and Meta-Analysis of Observational Studies
por: Peng, Ying, et al.
Publicado: (2016)

Splanchnic Vein Thrombosis: Etiology, Diagnosis, and Treatment
por: Qi, Xingshun, et al.
Publicado: (2015)

Acute kidney injury defined by cystatin C may be superior for predicting the outcomes of liver cirrhosis with acute gastrointestinal bleeding
por: Hong, Cen, et al.
Publicado: (2022)

Recombinant factor VIIa for variceal bleeding in liver cirrhosis: still only a hope
por: Qi, Xingshun, et al.
Publicado: (2017)

Management of decompensated liver cirrhosis in the surgical intensive care unit
por: Kasper, Philipp, et al.
Publicado: (2023)

Sarcopenia and blood myokine levels as prognostic biomarkers in patients with liver cirrhosis or hepatocellular carcinoma
por: Oh, Sooyeon, et al.
Publicado: (2020)

Management of chronic liver diseases and cirrhosis: current status and future directions
por: Xu, Jing-Hang, et al.
Publicado: (2020)

A need for patient-centered care in managing patients with liver cirrhosis
por: Yoon, Eileen L.
Publicado: (2021)

Quantification of ascites based on abdomino-pelvic computed tomography scans for predicting the in-hospital mortality of liver cirrhosis
por: Wang, Ran, et al.
Publicado: (2017)

Role of D-dimer in the Development of Portal Vein Thrombosis in Liver Cirrhosis: A Meta-analysis
por: Dai, Junna, et al.
Publicado: (2015)

Association of coagulopathy with the risk of bleeding after invasive procedures in liver cirrhosis
por: Li, Jing, et al.
Publicado: (2018)

Does Hepatic Impairment Influence Renal Function Parameters in Liver Cirrhosis?
por: Song, Tingxue, et al.
Publicado: (2018)

Regression of liver cirrhosis: Orthodoxy or paradigm shift?
por: Yu, Su Jong
Publicado: (2015)

Critical issues in the diagnosis and treatment of liver cirrhosis
por: Wang, Xing, et al.
Publicado: (2019)

Liver cirrhosis and sarcopenia: a dreadful combination
por: Kuchay, Mohammad Shafi, et al.
Publicado: (2022)

Association between Portal Vein Thrombosis and Survival in Non-Liver-Transplant Patients with Liver Cirrhosis: A Systematic Review of the Literature
por: Qi, Xingshun, et al.
Publicado: (2015)

Practice guidance for the use of terlipressin for liver cirrhosis–related complications
por: Qi, Xingshun, et al.
Publicado: (2022)

Comparison of liver biochemical abnormality between COVID-19 patients with liver cirrhosis versus COVID-19 alone and liver cirrhosis alone: A STROBE observational study
por: An, Yang, et al.
Publicado: (2021)

Development and Validation of CAGIB Score for Evaluating the Prognosis of Cirrhosis with Acute Gastrointestinal Bleeding: A Retrospective Multicenter Study
por: Bai, Zhaohui, et al.
Publicado: (2019)

Impact of spider nevus and subcutaneous collateral vessel of chest/abdominal wall on outcomes of liver cirrhosis
por: Li, Hongyu, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_hpqp4ooo54et7fg74ej3k5ggit